Clinical Research
Hope Biosciences Receives First RMAT Designation For Stem Cell Therapy In Multiple Sclerosis
Leading U.S. stem cell banking and cellular therapeutic manufacturer Hope Biosciences announces the U.S. Food and Drug Administration (FDA) has g...
August 28, 2025 | News
Avance Clinical Guides 710 Emerging Biotechs Through Critical Early-Phase Milestones
Avance Clinical, a partner for biotechs providing global contract research organization services, has now guided 710 emerging biotechs through critical cli...
August 28, 2025 | News
Neusoft Medical Secures China’s First Approval For Photon-Counting CT With NeuViz P10
Neusoft Medical Systems announced that its NeuViz P10 photon-counting CT has received market approval from China's National Medical Product...
August 28, 2025 | News
Akeso Reports Positive Phase 3 Results For Gumokimab In Ankylosing Spondylitis And Manfidokimab In Atopic Dermatitis
Akeso Inc. announced positive results from its Phase 3 clinical trial of gumokimab (AK111), a novel, fully human anti-IL-17A monoclonal antibod...
August 26, 2025 | News
Lighthouse Pharma Secures $49.2M NIH Grant to Launch Phase 2 Alzheimer’s Trial in the United States
Groundbreaking Clinical Trial to Enroll 300 Patients in Double-Blind, Placebo-Controlled Study of Lysine-Gingipain Inhibitor Lighthouse Pharmaceuticals, a...
August 25, 2025 | News
SMSbiotech Launches First-in-Human Trial of Small Mobile Stem Cells for COPD in Australia
SMSbiotech, a San Diego–based leader in regenerative medicine, announced the initiation of its first-in-human Phase 1 clinical trial for C...
August 22, 2025 | News
Japan’s ARC Therapies Initiates Research on Novel Gut Microbe YB328 for Cancer Immunotherapy
ARC Therapies Inc. (Head Office: Shinjuku, Tokyo; President & CEO: Rami Suzuki), a certified startup from the National Cancer Cente...
August 21, 2025 | News
Akeso Doses First Patient in Phase III COMPASSION-33 Trial of Cadonilimab for Perioperative Gastric Cancer
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the enrollment and dosing of the first patient in the pivotal Phase III clinical trial (AK104-31...
August 21, 2025 | News
LabConnect Launches LabConnector™ to Transform Clinical Trial Data Management
LabConnect, LLC, a global leader in central laboratory services for clinical trials, announced the launch of LabConnector™, a powerful new techn...
August 20, 2025 | News
Mabwell Secures FDA IND Clearance for CDH17-Targeting ADC 7MW4911 in Advanced GI Cancers
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D cod...
August 20, 2025 | News
Ascletis Reports 44.8% Weight Reduction in Obese Mouse Model with Combination of ASC47 and Novel Dual GLP-1R/GIPR Agonist ASC31
Combination of a low dose of ASC47 with ASC31, a novel peptide agonist targeting both GLP-1 receptor (GLP-1R) and GIP receptor (GIPR), ...
August 19, 2025 | News
IQVIA and Veeva Forge Global Clinical and Commercial Partnerships, Resolve Legal Disputes
IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Und...
August 19, 2025 | News
WuXi XDC Delivers 62% Revenue Growth and Record Project Momentum in H1 2025
- Revenue increased by 62.2% YoY to RMB 2,701 million - Gross profit surged by 82.2% YoY to RMB 975 million, with i...
August 19, 2025 | Company results
GenScript Biotech CEO Sherry Shao Champions Innovation and Global Expansion as H1 2025 Profits Surge Over 500%
GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 20...
August 18, 2025 | Company results
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
